# The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients

> **NCT06243536** · PHASE4 · UNKNOWN · sponsor: **University Hospital Sestre Milosrdnice** · enrollment: 60 (estimated)

## Conditions studied

- Type 2 Diabetes
- Overweight
- Disordered Eating Behaviors

## Interventions

- **DRUG:** Semaglutide
- **DRUG:** standard of care

## Key facts

- **NCT ID:** NCT06243536
- **Lead sponsor:** University Hospital Sestre Milosrdnice
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06243536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06243536, "The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06243536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*